Farther Finance Advisors, LLC
Position in TMCI — Treace Medical Concepts, Inc.
CIK 1992825
SAN FRANCISCO, CA
Position in TMCI
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$33,034
+$22,144 QoQ
Shares Held
8,300
+2.1% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#86
of 116 holders
Holding Since
Dec 2023
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in TMCI Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Farther Finance Advisors, LLC holds $24,008,567 across 89 Medical Devices names. TMCI ranks #24 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
73,946 | $6,709,860 | |
| 2 | SYK |
Stryker Corp
|
17,426 | $5,486,401 | |
| 3 | MDT |
Medtronic plc
|
65,993 | $5,162,632 | |
| 4 | BSX |
Boston Scientific Corp
|
28,699 | $1,224,873 | |
| 5 | EW |
Edwards Lifesciences Corp
|
12,482 | $1,129,121 | |
| 6 | DXCM |
Dexcom Inc
|
9,967 | $671,277 | |
| 7 | STE |
STERIS plc
|
2,980 | $627,498 | |
| 8 | GEHC |
GE HealthCare Technologies Inc.
|
8,545 | $546,965 |
All Filings in TMCI
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $33,034 | 8,300 | Shares | Sole | 2026-07-17 | |
| 2026-03-31 | $10,890 | 8,127 | Shares | Sole | 2026-04-07 | |
| 2025-12-31 | $19,600 | 8,000 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $4,683 | 698 | Shares | Sole | 2025-10-14 | |
| 2025-06-30 | $27,735 | 4,717 | Shares | Sole | 2025-07-11 | |
| 2024-06-30 | $1,170 | 176 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $1,030 | 79 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $1,262 | 99 | Shares | Sole | 2024-02-15 | |
| No filing history on record for this holder in this stock. | ||||||